PREZCOBIX PED 600 MG / 90 MG Tablet for Oral Suspension

RxCUI: 2738999
RxNorm name: PREZCOBIX PED 600 MG / 90 MG Tablet for Oral Suspension
Display name: PREZCOBIX PED 600 MG / 90 MG Tablet for Oral Suspension
Full name: PREZCOBIX PED 600 MG / 90 MG Tablet for Oral Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PREZCOBIX	DARUNAVIR ETHANOLATE AND COBICISTAT	Janssen Products, LP	9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f	2026-02-01	Warnings, Adverse reactions	Exact identifier rxcui: 2738999

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f	PREZCOBIX PED 600 MG / 90 MG Tablet for Oral Suspension [PSN] · cobicistat 90 MG / darunavir 600 MG Tablet for Oral Suspension [Prezcobix] [SBD] · Prezcobix 600 MG (as darunavir ethanolate ) / 90 MG Tablet for Oral Suspension [SY]	3	28	These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 2015	20260201